SAB Biotherapeutics, Inc. (SABS, SABSW)

CIK 1833214 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for SAB Biotherapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 21, 2026424B30001193125-26-361180
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352646
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005263
Aug 14, 2026SCHEDULE 13G/A0001727492-26-000022
Aug 14, 2026SCHEDULE 13G/A0001831942-26-000035
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003437
Aug 14, 2026SCHEDULE 13G/A0001213900-26-090054
Aug 12, 2026SCHEDULE 13G0000919574-26-004984
Aug 10, 2026SCHEDULE 13D/A0001346824-26-000220
Aug 6, 202610-Q0001193125-26-336783
Jul 7, 20268-K0001193125-26-296936
Jun 26, 202640001193125-26-285722
Jun 18, 20268-K0001193125-26-275976
May 15, 2026SCHEDULE 13G0001193125-26-225169
May 15, 2026SCHEDULE 13G0001727492-26-000011
May 15, 2026SCHEDULE 13G/A0001193125-26-226560
May 12, 202610-Q0001193125-26-218195
May 4, 20268-K0001193125-26-204125
May 1, 2026SCHEDULE 13G0001104659-26-054220
Apr 30, 2026DEF 14A0001193125-26-197607
Apr 22, 20268-K0001193125-26-168569
Mar 31, 2026S-80001193125-26-134733
Mar 25, 202640001193125-26-124231
Mar 23, 2026SCHEDULE 13D/A0001346824-26-000079
Mar 19, 2026424B50001193125-26-114728